AML3D (ASX:AL3) share price on watch following body armour development

The AML3D Ltd (ASX: AL3) share price will be on watch this morning following the company's progression of its next-gen body armour program.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The AML3D Ltd (ASX: AL3) share price will be on watch this morning. This comes after yesterday's market close announcement that the company is progressing with its next-gen body armour program.

close up of man's eye looking through magnifying glass representing asx 200 share price on watch

Image source: Getty Images

Progression to stage 2 development

The AML3D share price could be on the move today after the company advised its next-gen body armour program has progressed to the second stage.

According to the release, AML3D's 'made-to-fit' titanium body armour entered the next stage of prototype development with Lightforce Australia Pty Ltd.

Lightforce is a developer and manufacturer of defence solutions with operations in Australia and the United States.

Production of the innovative, high-tech body armour is under direct supervision of AML3D's Wire Arc Manufacturing division. It is stated that the prototype is uniquely printed in a way that is not possible using traditional techniques. Potential applications include creating 'made-to-fit' body armour by scanning the torsos of individual soliders. 

The first stage of the program marked the beginning of the Memorandum of Understanding (MoU) with Lightforce and involved product testing. The second stage will encompass ballistics testing with additional prototypes. These samples will be used with a variety of thicknesses and finished using a range of different techniques and treatments. The end goal for AML3D is to optimise the design to deliver the lightest, yet strongest armour to market.

Finalisation of the second stage will conclude the testing phase under the MoU. AML3D will spend $55,000 on providing several prototypes to Lightforce for testing.

AML3D advised it is confident it will succeed in developing the next-gen body armour product for commercialisation. The company also noted the opportunity for contract manufacturing revenues is significant.

According to AML3D, the market for such a product is expected to be above US$3 billion by 2025, representing a compound annual growth rate of 5.5%.

Management commentary

AML3D managing director, Mr Andrew Sales, was pleased with the company's achievements. He said:

We're excited to progress to Stage 2 with Lightforce in the development of a disruptive, world- first product offering. We're confident that our highly qualified team will be able to deliver a range of prototypes that meet or exceed Lightforce's required specifications.

Post the recent capital raise, AML3D is now well capitalised to fulfil the demands of opportunities such as Lightforce, which have the potential to deliver significant contract manufacturing revenues.

About the AML3D share price

The AML3D share price has risen strongly since its initial public offering (IPO) earlier this year. Back in April, AML3D shares were asking just 15 cents but have since increased to 42 cents as at yesterday's close. This reflects a gain of 180% for investors who held the company's shares over this eight month period.

The AML3D share price reached an all-time high of 73 cents in September, and has been gradually trending lower in the months following.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

a group of business people sit dejectedly around a table, each expressing desolation, sadness and disappointment by holding their head in their hands, casting their gazes down and looking very glum.
Share Fallers

DroneShield shares tumble 17% as CEO exit revives leadership fears

Investors bank gains as DroneShield leadership reset unsettles sentiment...

Read more »

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Domino's and Pro Medicus shares

A leading analyst expects Domino’s and Pro Medicus shares to keep underperforming.

Read more »

A young man goes over his finances and investment portfolio at home.
Broker Notes

Buy, hold, sell: Coles, Endeavour, and Rio Tinto shares

The team at Morgans has given its verdict on these popular shares.

Read more »

Focused man entrepreneur with glasses working, looking at laptop screen thinking about something intently while sitting in the office.
Broker Notes

Morgans names two ASX 200 shares to buy and one to sell this week

Let's see which shares Morgans is bullish and bearish on this week.

Read more »

Three scientists wearing white coats and blue gloves dance together in a lab.
Broker Notes

Why beaten down CSL shares now offer 'long-term appeal'

A leading expert gives his outlook for CSL’s beaten down shares.

Read more »

A white and black clock face is shown with three hands saying Time to Buy reflecting Citi's view that it's time to buy ASX 200 banks
Broker Notes

3 compelling reasons to buy QBE shares today

A top expert forecasts more outperformance from QBE shares.

Read more »

Falling prices of oil demonstrated by a red arrow and barrels of oil.
Energy Shares

ASX shares to watch as oil price crashes

The turnaround in oil prices is a huge headwind for the ASX shares.

Read more »